Abstract: New drugs or other new treatments are commonly assessed to see if they are cost-effective, based on the use of health economic models. As end users, patients are important stakeholders in these decisions but are rarely involved in developing the economic models. This article considers the possible benefits and risks of patient involvement in model development. Benefits of becoming involved would include a greater understanding and possible acceptance by patients of the models and better models informed by the patient expertise. The authors claim that the benefits may outweigh the risks and that patients should become involved.
External link: The following links will take you to information on this entry on an external website. INVOLVE is not responsible for the content or the reliability of the external websites. Click here
Related entry: none currently available
Categories: health nature and extent of public involvement in research journal article
Date Entered: 2019/03/04
Date Edited: 2019/03/04